Exacerbation of idiopathic Parkinson's disease by naproxen.
作者信息
Shaunak S, Brown P, Morgan-Hughes J A
机构信息
National Hospital for Neurology and Neurosurgery, London.
出版信息
BMJ. 1995 Aug 12;311(7002):422. doi: 10.1136/bmj.311.7002.422b.
Abstract
摘要
相似文献
1
Exacerbation of idiopathic Parkinson's disease by naproxen.
BMJ. 1995 Aug 12;311(7002):422. doi: 10.1136/bmj.311.7002.422b.
2
Increase of Parkinson disability after fluoxetine medication.服用氟西汀后帕金森病残疾程度加重。
Neurology. 1993 Jan;43(1):211-3. doi: 10.1212/wnl.43.1_part_1.211.
3
Is it Parkinson's disease?这是帕金森病吗？
Aust Fam Physician. 1992 Oct;21(10):1411-6.
4
Clinically silent idiopathic Parkinson's disease unmasked by valproate use: a brief report.
Aging Clin Exp Res. 2015 Jun;27(3):387-90. doi: 10.1007/s40520-014-0278-z. Epub 2014 Nov 1.
5
Environmental determinants of Parkinson's disease.帕金森病的环境决定因素
Arch Environ Occup Health. 2005 Jan-Feb;60(1):32-8. doi: 10.3200/AEOH.60.1.32-38.
6
Drug induced Parkinson's disease.药物性帕金森病
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1457. doi: 10.1136/bmj.288.6428.1457-b.
7
Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism.帕金森病的运动和非运动特征可预测持续性药物诱导的帕金森病。
Parkinsonism Relat Disord. 2014 Jul;20(7):738-42. doi: 10.1016/j.parkreldis.2014.03.024. Epub 2014 Apr 1.
8
Not Parkinson's disease.不是帕金森病。
Lancet. 1982 Jul 3;2(8288):49.
9
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis.[¹²³I]FP - CIT单光子发射计算机断层扫描（DaTSCAN）可能是区分帕金森病与血管性或药物性帕金森综合征的有用工具：一项荟萃分析。
Eur J Neurol. 2014 Nov;21(11):1369-e90. doi: 10.1111/ene.12444. Epub 2014 Apr 30.
10
The MPTP model of Parkinson's disease.帕金森病的MPTP模型。
Brain Res Mol Brain Res. 2005 Mar 24;134(1):57-66. doi: 10.1016/j.molbrainres.2004.09.017.
引用本文的文献
1
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.靶向小胶质细胞激活状态作为帕金森病的一种治疗途径。
Front Aging Neurosci. 2017 Jun 8;9:176. doi: 10.3389/fnagi.2017.00176. eCollection 2017.
2
M1 and M2 immune activation in Parkinson's Disease: Foe and ally?帕金森病中的M1和M2免疫激活：敌人还是盟友？
Neuroscience. 2015 Aug 27;302:59-73. doi: 10.1016/j.neuroscience.2014.11.018. Epub 2014 Nov 25.
3
Drug-induced movement disorders.药物性运动障碍
Drug Saf. 1997 Mar;16(3):180-204. doi: 10.2165/00002018-199716030-00004.
本文引用的文献
1
Extrapyramidal symptoms following mefenamic acid.甲芬那酸后的锥体外系症状
J R Soc Med. 1983 May;76(5):435. doi: 10.1177/014107688307600533.
2
Diflunisal in idiopathic Parkinson's disease.双氟尼酸治疗特发性帕金森病
Neurology. 1984 Mar;34(3):400. doi: 10.1212/wnl.34.3.400.
3
Extrapyramidal reactions to anti-inflammatory drugs.抗炎药物的锥体外系反应。
J Neurol Neurosurg Psychiatry. 1988 May;51(5):731-2. doi: 10.1136/jnnp.51.5.731.
4
Acute exacerbation of Parkinson's disease with sulindac.舒林酸引发的帕金森病急性加重
Ann Neurol. 1985 Jan;17(1):104-5. doi: 10.1002/ana.410170124.
5
Acute parkinsonism associated with flurbibrofen.与氟比洛芬相关的急性帕金森综合征
BMJ. 1990 Feb 24;300(6723):540-1. doi: 10.1136/bmj.300.6723.540-c.
Zotero 插件